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Concentrations of thyroid gland hormones in maternal and
fetal serum and in amniotic fluid after intraamnial
application of thyroxine
J.W. DUDENHAUSEN
Studies performed on rats, rabbits and lambs have shown
that thyroxine stimulates the phospholipid production in
the fetal lung. In human beings intraamnial instillation
of thyroxine should increase lung maturity and lower the
number of cases of membrane syndrome.
The aim of our examinations on 22 pregnant patients with
a gestational age of under 35 weeks, was to follow the
course of the thyroid gland hormone concentration in
amniotic fluid, and in maternal and fetal serum after
giving an intraamnial dosage of 5OO ug levothyroxine.
The hormone determinations were done radioimmunological-
ly and the lecithin was determined encymatically.
Groups were drawn up according to the interval between
the instillation of T^ in the amniotic fluid and fresh
amniotic fluid withdrawal, normally when the membranes
ruptured at the start of labour, in this way a limit of
5 days was empirically created. In 12 cases the inter-
val was the same or less than 5 days (Group A ) , in the
remaining 1O cases the time interval was more than 5
days (Group B ) .
Amniotic fluid: The mean value of the T. concentration
rises in Group A 18 times as much; in Group B the con-
centration is no different from the original level. The
mean value of the rT3 concentrations after T. injections
into the amniotic fluid points to a significant in-
crease, about 13 times as much. In Group B no differ-
ence can be seen.
Umbilical cord blood; Whilst the T. and rT~ concentra-
tions in Group A and B are significantly different, the
T3 concentrations are similar in both groups.
Maternal serum; The concentrations of Τ . , T ~ , and rT
were measured before, 1/2 an hour after and 24 hours3
after T4 injections into the amniotic fluid. No signi-
ficant changes were to be seen in maternal blood.
The results must be interpreted so that the T. injection
into the amniotic fluid leads to an increase of T in
the fetal blood. This clearly shows that the T-injected
into the amniotic fluid is resorbed by the fetus. How-
ever in the group where the interval between injection
and delivery was more than 5 days, we observed that the
T4 level had normalised again.
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The thyroid gland hormones resorbed by the fetus will
exercise their effect on various fetal organs. As an
expression of the cardial effect of the thyroid gland
hormones after thyroxine injection we found a moderate
fetal tachycardia in 5 cases two days after the injec-
tion.
It seems that there is no paraplacental passage of the
T. injected into the amniotic fluid into the maternal
blood.
In addition to the hormone examination we also tested
the lecithin concentrations in amniotic fluid before and
after T. injections; we observed a significant increase
of the median values from 3,5 mg/1OO ml to 5,2 mg/1OO ml
after injection. The mean value in Group A was 5,6 mg/
1OO ml and in Group B 4 ,3 mg/1OO ml. The induction of
surfactant production by means of thyroxine probably
creates a reversible effect mechanism.
In this connection the membrane syndromes diagnosed by
neonatologists are important: Whilst in our group about
8 cases of membrane syndrome were to be expected, this
diagnosis had only been made in 2 cases.
It must be said that the risks involved in giving thyro-
xine with regard to the increase in oxygen output are
not certain, whereby this increase does not necessarily
have to be the same in all organs. The question of in-
creased oxygen output of T - injection would be of parti-
cular importance when dealing with fetuses with respira-
tory placental insufficiency.
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